Khalid Ibrahim Abd El Ghany

Prof. Dr. Khalid Ibrahim Abd El Ghany

Microbial biotechnology, Egyptian Drug Authority, Cairo, Al Qāhirah, Egypt
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 July 2022 in Fermentation
Verified
Journal Article
Open access
PDF file
Shatha Abdullah AllaithShatha Abdullah Allaith
Shatha Abdullah Allaith
MAMohamed E. Abdel-aziz
Mohamed E. Abdel-aziz
ZTZaid Akram Thabit
Zaid Akram Thabit
Ammar AltemimiAmmar Altemimi
Ammar Altemimi
KGKhalid Ibrahim Abd El Ghany
Khalid Ibrahim Abd El Ghany
Tarek Gamal AbedelmaksoudTarek Gamal Abedelmaksoud
Tarek Gamal Abedelmaksoud
The goal of this study was screening and molecular identification of Lactic Acid Bacteria (LAB) producing β-glucan from different species isolated from boza and cider compared to a standard strain for Lactobacillus rhamnosus NRRL 1937 (LGG). From 48 unknown isolates, four LAB strains were selected. Based on the NCBI database, their nomenclature was A3, B6, and C9 for Limosilactobacillus fermentum SH1, SH2, and SH3 along with D6 for Leuconostoc mesenteroides SH4. Also, their similarity values were 100%, 99.8%, 100%, and 100%, respectively. The potential of Exopolysaccharide (EPS) (as β-glucan) production for selected LAB strains by gtf gene, conventional PCR and gene expression using both LGG as a control and LAB 16S rRNA gene as a house-keeping gene was investigated. In addition, EPS (mg/100 mL), cell mass (mg/100 mL), pH, total carbohydrate%, total protein% and β-glucan% by the HPLC for all selected LAB isolates were studied. All results of genetic and chemical tests proved the superiority of B6 treatment for L. fermentum SH2. The results showed the superiority of B6 treatment in gtf gene expression (14.7230 ± 0.070-fold) followed by C9 and A3 treatments, which were 10.1730 ± 0.231-fold and 8.6139 ± 0.320-fold, respectively. while D6 treatment recorded the lowest value of gene expression (0.8566 ± 0.040-fold) compared to the control LGG (one-fold). The results also demonstrated that B6 treatment was superior to the other treatments in terms of EPS formation, with a value of 481 ± 1.00 mg/100 mL, followed by the C9 treatment at 440 ± 2.00 mg/100 mL, compared to the LGG (control) reaching 199.7 ± 3.51 mg/100 mL. Also, the highest % of quantitative and qualitative β-glucan in EPS was observed in B6 followed by C9, D6 and A3 which were 5.56 ± 0.01%, 4.46 ± 0.01%, 0.25 ± 0.008% and 0.12 ± 0.008%, respectively compared to control (0.31 ± 0.01%). Finally, the presented results indicate the importance of screening the local LAB isolates to obtain a superior strain for β-glucan production which will be introduced in a subsequent study under optimum conditions.

19 June 2023 in Metabolites
Verified
Journal Article
Open access
PDF file
MAMetab Algeffari
Metab Algeffari
DMDina Farouk Mansour
Dina Farouk Mansour
OAOmar Ahmed-Farid
Omar Ahmed-Farid
EYEinas Yousef
Einas Yousef
SMshereen mustafa
shereen mustafa
KGKhalid Ibrahim Abd El Ghany
Khalid Ibrahim Abd El Ghany
Lactic acid bacteria is well-known as a vital strategy to alleviate or prevent diabetes. Similarly, the plant Saussurea costus (Falc) Lipsch is a preventive power against diabetes. Here, we aimed to determine whether lactic acid bacteria or Saussurea costus is more effective in treating a diabetic rat model in a comparative study manner. An in vivo experiment was conducted to test the therapeutic activity of Lactiplantibacillus plantarum (MW719476.1) and S. costus plants against an alloxan-induced diabetic rat model. Molecular, biochemical, and histological analyses were investigated to evaluate the therapeutic characteristics of different treatments. The high dose of S. costus revealed the best downregulated expression for the IKBKB, IKBKG, NfkB1, IL-17A, IL-6, IL-17F, IL-1β, TNF-α, TRAF6, and MAPK genes compared to Lactiplantibacillus plantarum and the control groups. The downregulation of IKBKB by S. costus could be attributed to dehydrocostus lactone as an active compound with proposed antidiabetic activity. So, we performed another pharmacophore modeling analysis to test the possible interaction between human IkB kinase beta protein and dehydrocostus lactone as an antidiabetic drug. Molecular docking and MD simulation data confirmed the interaction between human IkB kinase beta protein and dehydrocostus lactone as a possible drug. The target genes are important in regulating type 2 diabetes mellitus signaling, lipid and atherosclerosis signaling, NF-κB signaling, and IL-17 signaling pathways. In conclusion, the S. costus plant could be a promising source of novel therapeutic agents for treating diabetes and its complications. Dehydrocostus lactone caused the ameliorative effect of S. costus by its interaction with human IkB kinase beta protein. Further, future studies could be conducted to find the clinical efficacy of dehydrocostus lactone.

30 March 2025 in Food Bioscience
Verified
Journal Article
Closed access
KGKhalid Ibrahim Abd El Ghany
Khalid Ibrahim Abd El Ghany
LML.O. Mallasiy
L.O. Mallasiy
SHShimaa A. Haredy
Shimaa A. Haredy
OAOmar Ahmed-Farid
Omar Ahmed-Farid
BABarga Aboukhezam
Barga Aboukhezam
NENaglaa Elshafey
Naglaa Elshafey

2 October 2024 in Microbial Pathogenesis
Verified
Journal Article
Closed access
SASafia ahmed Amin
Safia ahmed Amin
MDMohamed E.A. Dawood
Mohamed E.A. Dawood
DBDina M. Bassiouny
Dina M. Bassiouny
MMMahmoud M. A. Moustafa
Mahmoud M. A. Moustafa
KGKhalid Ibrahim Abd El Ghany
Khalid Ibrahim Abd El Ghany

15 July 2025 in Food Bioscience
Verified
Journal Article
Closed access
MBManal A. Babaker
Manal A. Babaker
KGKhalid Ibrahim Abd El Ghany
Khalid Ibrahim Abd El Ghany
NENaglaa Elshafey
Naglaa Elshafey
AAAyman Mohamed Algohary
Ayman Mohamed Algohary
EEEhab Elgohary
Ehab Elgohary
OAOmar Ahmed-Farid
Omar Ahmed-Farid

1 April 2026 in Egyptian Journal of Medical Microbiology
Verified
Journal Article
Closed access
NMNawal M. Mohamed
Nawal M. Mohamed
DEDawlat T Ezzat
Dawlat T Ezzat
MDMohamed E.A. Dawood
Mohamed E.A. Dawood
KGKhalid Ibrahim Abd El Ghany
Khalid Ibrahim Abd El Ghany
Background: Multidrug-resistant (MDR) pathogens pose a serious global health threat, emphasizing the need for alternative antimicrobial strategies. Objective: This study aimed to investigate the antimicrobial, anti-virulence, and antioxidant properties of 33 essential oils against clinical isolates of Escherichia coli (n=4) and Klebsiella pneumoniae (n=2). Methodology: Clinical isolates were obtained from Kasr Al Ainy Hospital, and antimicrobial activity was assessed using disc diffusion and broth microdilution assays. Minimum inhibitory concentrations (MICs) and minimum bactericidal concentrations (MBCs) were determined, virulence gene expression was analysed by qPCR, antioxidant capacity was evaluated using the DPPH radical scavenging assay, and phytochemical profiles were identified via LC-MS. (Results). Thyme oil (oil 25) and cinnamon oil (oil 29) exhibited the most potent antimicrobial activity, with inhibition zones up to 26 mm. Cinnamon oil had a consistent MIC of 0.0488% against all strains, while thyme ranged from 0.0488% to 0.0975%; MBCs varied by strain. Cinnamon oil significantly downregulated fimH, ompA, iss, and luxS in E. coli, and uge, mrkA, fimH, and rmpA in K. pneumoniae. Antioxidant activity was higher in cinnamon (70.57%) than in thyme (67%). LC-MS revealed thymol and carvacrol in thyme, and cinnamaldehyde and eugenol in cinnamon.(Conclusion: These findings demonstrate that thyme and cinnamon oils act through combined antimicrobial effects, virulence suppression, and antioxidant protection, supporting their potential as natural adjuvants against MDR pathogens.